Featured Article
A variant in a immune system gene increases the likelihood of severe ulcerative colitis in those who carry the mutation. Researchers tested almost 5,000 people with ulcerative colitis to assess the impact of genetics on severity of their condition.
Precision Oncology Today
Magazine
5 Key Startups Bringing Digital Pathology Into Focus
Digital pathology is driving precision medicine by turbocharging the analysis of tissue slides. Here are the five top startups turning microscopy into a data...
How Is Artificial Intelligence Changing the Clinical Trials Landscape?
There is no doubt that artificial intelligence (AI) is currently en vogue. Many AI and machine-learning applications are already being deployed in drug discovery and development. Not only can AI process, analyze, and interpret huge datasets, it can also be used for structural drug design and toxicity and efficacy predictions.
Trending on Inside Precision Medicine
Behind The Breakthroughs: The Tipping Point for Adopting Precision Medicine
In the premier episode, Dr. Geoff Oxnard of Lilly and Boston Medical Center discusses barriers to precision medicine adoption and how to overcome them.
New Biomarker Predicts Immunotherapy Response in Hepatocellular Carcinoma
The findings detail the role of two proteins, p62 and NBR1, and their opposing functions in regulating interferon response in hepatic stellate cells, an important component in the liver’s immune response against tumors.
Genetic Variant Could Predict Severe Ulcerative Colitis
A variant in a immune system gene increases the likelihood of severe ulcerative colitis in those who carry the mutation. Researchers tested almost 5,000 people with ulcerative colitis to assess the impact of genetics on severity of their condition.
